Ausgabe 3/2007
Inhalt (13 Artikel)
Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma
Eriko Tokunaga, Eiji Oki, Yasue Kimura, Takeharu Yamanaka, Akinori Egashira, Kojiro Nishida, Tadashi Koga, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis
Kejin Wu, Zhiwei Quan, Ziyi Weng, Fangming Li, Yichu Zhang, Xiaohong Yao, Yiding Chen, Daniel Budman, Itzhak D Goldberg, Y. Eric Shi
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers
Eunsil Yu, Yeon Sun Ahn, Se Jin Jang, Mi-Jung Kim, Ho Sung Yoon, Gyungyub Gong, Jene Choi
Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis
Mario R. D’Andrea, Maria R. Limiti, Mario Bari, Pamela Zambenedetti, Adriana Montagutti, Francesca Ricci, Giovanni L. Pappagallo, Donata Sartori, Orazio Vinante, Pietro L. Mingazzini
Long-Term Management of Breast Cancer-Related Lymphedema after Intensive Decongestive Physiotherapy
Stéphane Vignes, Raphaël Porcher, Maria Arrault, Alain Dupuy
Accuracy and Underestimation of Malignancy of Breast Core Needle Biopsy: the Florence Experience of Over 4000 Consecutive Biopsies
Stefano Ciatto, Nehmat Houssami, Daniela Ambrogetti, Simonetta Bianchi, Rita Bonardi, Beniamino Brancato, Sandra Catarzi, Gabriella G. Risso
Differential Roles of Angiotensinogen and Angiotensin Receptor type 1 Polymorphisms in Breast Cancer Risk
A. M. González-Zuloeta Ladd, A. Arias Vásquez, C. Siemes, M. Yazdanpanah, J. W. Coebergh, A. Hofman, B. H. Ch. Stricker, C. M. van Duijn
Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers
Asako Ooe, Kikuya Kato, Shinzaburo Noguchi
Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer
Hongyu Wu, Kangmin Zhu, Ismail Jatoi, Mona Shah, Craig D. Shriver, John Potter
Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole
C. Skedgel, D. Rayson, R. Dewar, T. Younis
The management of ductal carcinoma in situ of the breast: a screened population-based analysis
Eileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, Wedad Hanna, Hariette Kahn, John Wong, Verna Mai, Lawrence Paszat
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature
Alberto Luini, Marisel Aguilar, Giovanna Gatti, Roberta Fasani, Edoardo Botteri, Jack Antonio Diaz Brito, Patrick Maisonneuve, Anna Rita Vento, Giuseppe Viale
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
Giampietro Gasparini, Massimo Gion, Luigi Mariani, Paola Papaldo, Diana Crivellari, Gianfranco Filippelli, Alessandro Morabito, Vittorio Silingardi, Francesco Torino, Antonella Spada, Matelda Zancan, Livia De Sio, Antonio Caputo, Francesco Cognetti, Antonio Lambiase, Dino Amadori